Glycopyrrolate Injection
Product Images NDC 71872-7238

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7238-1.pdp (71872 7238 1)

This is a description of a medication, specifically Glycopyrrolate injection, which is not recommended for newborns and contains benzyl alcohol. The dosage should be determined based on the package insert. It is stored at a controlled room temperature of 20°C to 25°C and manufactured by Intas Pharmaceuticals Limited in India for Accord Healthcare, based in Durham, NC, USA. The medicine is repackaged and distributed by Medical Purchasing Solutions in Scottsdale, AZ, and their website is mentioned.*

FDA Label Image

Glycopyrrolate Structural Formula (Glycopyrrolate Injection 1)

FDA Label Image

Glycopyrrolate Injection, Usp 0.2 mg/ml 1 mL Single Dose Vial (Glycopyrrolate Injection 2)

Glycopyrrolate Injection, USP with NDC 16729-471-63 is a prescription medication manufactured for Accord Healthcare, Inc for intramuscular or intravenous administration. It comes in a 1 mL single-dose vial with Mfg. Lic. No- G/1026, Batch coding and INL5005. The usual dosage is not included, and users are advised to refer to the package insert for more information. The product contains Benzyl Alcohol and is intended for use in the USA. The image has a size of 9 x 17 mm.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.